Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-SRR Antibody (R2Q01)

Catalog #:   RHN66302 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: WB
Accession: Q9GZT4
Overview

Catalog No.

RHN66302

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

WB: 1:1000-1:2000

Target

D-serine dehydratase, SRR, L-serine dehydratase, L-serine ammonia-lyase, D-serine ammonia-lyase, Serine racemase

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9GZT4

Applications

WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2Q01

Data Image
  • Western blot
    Western blot analysis of Serine racemase expression in (1) 293 cell lysate; (2) U-87 MG cell lysate.
References

Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2/3 open-label study., PMID:40184816

Safety and Immunogenicity of the Tetravalent Recombinant COVID-19 Protein Vaccine SCTV01E in Children and Adolescents Aged 3 to 17 Years: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial., PMID:39852822

Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL., PMID:39820359

The changing treatment landscape of EGFR-mutant non-small-cell lung cancer., PMID:39614090

Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy., PMID:39374522

Effects of Topic Delivery of an Inhibitor of Serine Racemase on Laser-Induced Choroidal Vasculopathy., PMID:39136959

High glutamic acid decarboxylase antibody titers may be associated with a decline in β-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults., PMID:39084295

Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients-A Systematic Review., PMID:39065794

Development and validation of a claims-based algorithm to identify patients with Neuromyelitis Optica Spectrum disorder., PMID:38964269

Characterization of mAbs against Klebsiella pneumoniae type 3 fimbriae isolated in a target-independent phage display campaign., PMID:38940542

Validation of IgA nephropathy diagnosis in the Swedish Renal Registry., PMID:38438966

Immunogenicity of Tetravalent Protein Vaccine SCTV01E-2 against SARS-CoV-2 EG.5 Subvaraint: A Phase 2 Trial., PMID:38400158

Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity., PMID:38325903

Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma., PMID:37903325

BNC-rSS, a bivalent subunit nanovaccine affords the cross-protection against Streptococcus agalactiae and Streptococcus iniae infection in tilapia., PMID:37660857

Fulminant Anti-Myelin Oligodendrocyte Glycoprotein-Associated Cerebral Cortical Encephalitis: Case Series of a Severe Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Phenotype., PMID:37544084

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults., PMID:37438960

Systematic study of tissue factor expression in solid tumors., PMID:36806722

Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults., PMID:35998623

Engineering an autonomous VH domain to modulate intracellular pathways and to interrogate the eIF4F complex., PMID:35982046

SssP1, a Fimbria-like component of Streptococcus suis, binds to the vimentin of host cells and contributes to bacterial meningitis., PMID:35853077

Detection of G Protein-Coupled Receptor Autoantibodies in Postural Orthostatic Tachycardia Syndrome Using Standard Methodology., PMID:35766055

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials., PMID:35691871

Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study., PMID:35595661

Synthetic HLA-independent T cell receptors for cancer immunotherapy., PMID:35413270

Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)., PMID:35291289

Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis., PMID:34814865

The Efficacy and Safety of Different Dosages of Rituximab for Adults with Immune Thrombocytopenia: A Systematic Review and Meta-Analysis., PMID:34660807

Ganglionic Acetylcholine Receptor Antibodies in Postural Tachycardia Syndrome., PMID:34484936

Predicting the Course of Graves' Orbitopathy Using Serially Measured TSH-Receptor Autoantibodies by Automated Binding Immunoassays and the Functional Bioassay., PMID:34282595

A Novel Long-Term Graves' Disease Animal Model Confirmed by Functional Thyrotropin Receptor Antibodies., PMID:33511085

Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade., PMID:33357452

Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort., PMID:32731895

Sp4 controls constitutive expression of neuronal serine racemase and NF-E2-related factor-2 mediates its induction by valproic acid., PMID:32603878

Methylprednisolone pulse therapy in 31 patients with refractory epilepsy: A single-center retrospective analysis., PMID:32388139

Miller Fisher syndrome and polyneuritis cranialis in COVID-19., PMID:32303650

Full-length human GLP-1 receptor structure without orthosteric ligands., PMID:32152292

Subretinal injection of ranibizumab in advanced pediatric vasoproliferative disorders with total retinal detachments., PMID:32043167

B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling., PMID:32005952

Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease., PMID:31865369

Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy., PMID:31743392

Analysis of rabbit anti-thymocyte globulin vs basiliximab induction in pediatric liver transplant recipients., PMID:31512802

Comparison of a Bridge Immunoassay with Two Bioassays for Thyrotropin Receptor Antibody Detection and Differentiation., PMID:31207654

Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort., PMID:30935391

Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting., PMID:30889382

CD19-positive antibody-secreting cells provide immune memory., PMID:30478153

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia., PMID:30267011

Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella., PMID:30262653

Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice., PMID:29913163

Bacterial biogeography of adult airways in atopic asthma., PMID:29885665

Datasheet

Document Download

Anti-SRR Antibody (R2Q01).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-SRR Antibody (R2Q01) [RHN66302]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only